---
title: CDMO Daily News — September 23, 2026
slug: daily-news-2026-09-23-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: September 23 CDMO daily: Made Scientific Acquires Operational 85,000-Sq.-Ft. Cell Therapy GMP Facility in Pennsylvania; Sanner Rebrands Gilero, Expands…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-09-23-cdmo
published_at: 2026-09-23T00:00:56.685Z
last_updated: 2026-09-23T00:03:13.069Z
---

### [Made Scientific](/companies/madescientific) Acquires Operational 85,000-Sq.-Ft. Cell Therapy GMP Facility in Pennsylvania
- [Made Scientific](/companies/madescientific) closed acquisition of an operational 85,000-sq.-ft. cell therapy manufacturing facility in East Norriton, Pennsylvania from [National Resilience](/companies/resilience) on September 18, 2026.
- The facility has executed 145 GMP batches across autologous and allogeneic programs and includes eight Grade B/C cleanrooms, one Grade C ballroom, one Grade B fill-finish suite, and 30,000 sq. ft. of expansion space.
- Made Scientific plans to deploy 3D bioreactor platforms up to 200 liters, automated fill-finish, and lyophilization capacity; total U.S. East Coast footprint now reaches 145,000 sq. ft. with 15 qualified GMP suites.

**Operational Impact**

[Made Scientific](/companies/madescientific)'s acquisition of an operational facility with proven GMP batch history and immediate capacity eliminates ramp-up timelines for sponsors seeking 2027 clinical and commercial cell therapy supply, while the 30,000-sq.-ft. expansion plan and planned bioreactor/fill-finish upgrades position the East Norriton site as a scalable alternative to greenfield builds.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/made-scientific-acquires-85000-sq-ft-cell-therapy-manufacturing-facility)*

---

### [Sanner](/companies/sanner) Rebrands [Gilero](/companies/gilero), Expands Chicago Innovation Facility
- [Sanner](/companies/sanner) completed rebranding of acquired [Gilero](/companies/gilero) under unified global brand following 2024 acquisition and U.S. manufacturing capacity investments.
- Chicago facility expansion adds human factors lab, 3D printing, prototyping capabilities, and partnership access to mHUB Innovation Center for medtech development acceleration.

**Operational Impact**

[Sanner](/companies/sanner)'s Chicago facility expansion strengthens its medtech development footprint in the Midwest, reducing project risk and accelerating technology transfer for customers through integrated prototyping and human factors testing capabilities.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/sanner-rebrands-gilero-expands-chicago-facility)*

## References

1. [PharmaSource RSS — Made Scientific Acquires Operational 85,000-Sq.-Ft. Cell Therapy GMP Facility in Pennsylvania](https://pharmasource.global/content/news/cdmo-news/made-scientific-acquires-85000-sq-ft-cell-therapy-manufacturing-facility)
2. [Contract Pharma Breaking News RSS — Sanner Rebrands Gilero, Expands Chicago Innovation Facility](https://www.contractpharma.com/breaking-news/sanner-rebrands-gilero-expands-chicago-facility)

Source: https://www.cdmo.directory/posts/daily-news-2026-09-23-cdmo